| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |